Subjects in this paper were part of the Reduction by Dutasteride of PCa Events (REDUCE) study, a clinical trial enrolling men who had undergone a...
This study is from Dallas, USA and appears on the front cover of the BMJ. About 1 in 11 people will have a kidney stone...
Mirabegron is a beta-3 agonist used in the treatment of overactive bladder (OAB). Trials have shown reduced side-effects but equal efficacy when compared to anticholinergics....
The objective of this study was to review the clinical efficacy of currently available products for the intravesical treatment of bladder pain syndrome (BPS) /...
The aim of this systematic review was to evaluate the effectiveness of complementary therapies in the treatment of bladder pain syndrome. An electronic search identified...
This systematic review aimed to evaluate different surgical techniques and their outcomes used for treating women with urethral diverticulae. One hundred and eight studies were...
Whilst there is nothing unique in the individual chapters in this book it is rare for so many focused areas of interest to be integrated...
For many, a diagnosis of an underactive or atonic bladder represents the end of the line in terms of management options. It remains a poorly...
Men’s health has lagged behind its female equivalent as a specific medical subject but, over the past decade, campaigns by men’s health groups have started...
This article will be of great interest to uro-oncologists. Vertebral metastasis occurs in 3-5% of all cancers (most commonly in prostate, breast and lung cancer)....
While guidelines recommend flexible ureteroscopy (fURS) for treating renal stones 2cm; likely to increase in the future as scope and laser technology advances. Basket displacement...
The Memorial Sloan Kettering Cancer Center (MSKCC) developed prostate cancer screening recommendations first in 2011 as a response to three limitations of previous screening guidelines:...